Evaluation of Two Methods of Olfactory Rehabilitation in Post-viral Loss of Smell: Classic and Intensive
NCT ID: NCT04598763
Last Updated: 2020-10-22
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
80 participants
INTERVENTIONAL
2020-07-01
2021-01-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Hypothesis: Intensive or classic olfactory rehabilitation allows better results than spontaneous recovery
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
COVID-19: Post-covid Olfactory Disorders Assessment
NCT04799977
Does Olfactory Training Improve Olfaction in a Population With Normal Sense of Smell?
NCT02980718
Treatment of Postviral Olfactory Dysfunction
NCT06142565
Assessment of Olfactory Dysfunction in SARS CoV-2 (COVID-19) Infection
NCT04466982
Mindfulness-Based Stress Reduction Versus Lifestyle Intervention for Long-Haul Covid-19 Parosmia
NCT06789952
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The inclusion visit will be carried out during a standard routine care consultation with the following:
* an endoscopic endonasal examination
* the olfactory assessment (evaluation of smell by self-assessment, Dynachron-olfaction questionnaire, olfactory test by Sniffin 'Stick)
At the end of this assessment and after having received the information on the study and signed the consent form, the patients confirmed to be hypo-anosmic will then be randomized into 2 groups:
* "classic" olfactory rehabilitation group
* "intensive" olfactory rehabilitation group The rehabilitation kits (8 jars or 4 jars depending on the randomization group) will be provided to the patient with therapeutic education in their use.
The patient will carry out olfactory rehabilitation (intensive or classic) at home twice a day (morning and evening) for 32 weeks (i.e. 448 sessions). The patient will smell each odor for 10 seconds with an interval of 10 seconds between odors. Each training will be recorded by the patient in his olfactory rehabilitation agenda.
The patient will go again for a follow-up consultation for the renewal of his olfactory assessment at 4 months (follow-up visit 1) and at 8 months (follow-up visit 2) post-inclusion as part of the routine care of disorders of the smell post virus infection. In addition to the olfactory assessment during these visits, the investigator will also verify that the rehabilitation schedule is being kept.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
classic group
the "classic" group receives classic olfactory rehabilitation using 4 scents most used in the literature (rose, eucalyptus, lemon, clove)
smell the odors of the olfactory rehabilitation kit according to the classic or intensive method
regardless of the randomization group, the patient will smell each odor for 10 seconds with a 10 second interval between odors.
intensive
the "intensive" group receiving olfactory rehabilitation using 8 scents (rose, eucalyptus, lemon, cloves, strawberries, cut grass, lavender, spruce).
smell the odors of the olfactory rehabilitation kit according to the classic or intensive method
regardless of the randomization group, the patient will smell each odor for 10 seconds with a 10 second interval between odors.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
smell the odors of the olfactory rehabilitation kit according to the classic or intensive method
regardless of the randomization group, the patient will smell each odor for 10 seconds with a 10 second interval between odors.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patient with a sudden loss of smell\> 5 weeks linked to a viral infection (including SARS-CoV-2) of the upper respiratory tract treated in the ENT department of the CHRU Nancy
* Patient accepting olfactory rehabilitation
* Patient presenting with hyposmia or anosmia (confirmed by the threshold and identification tests of the Sniffin 'Stick kit)
* Patient affiliated to a social security scheme or beneficiary of such a scheme
* Patient who has received full research information and signed an informed consent.
Exclusion Criteria
Pregnant woman, parturient or nursing mother Person deprived of liberty by a judicial or administrative decision, Person undergoing psychiatric treatment under Articles L.3212-1 and L.3213-1 of the Public Health Code Minor (non-emancipated) Adult person subject to a legal protection measure (guardianship, curatorship, safeguard of justice) Adult person unable to express consent and who is not the subject of a legal protection measure
* Qualitative smell disorder (cacosmia, hyperosmia, phantosmia, parosmia)
* Neurological, post-traumatic, neurodegenerative, congenital odor disorders
* Post-infectious loss of smell\> 12 months
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Central Hospital, Nancy, France
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Duc Trung NGUYEN
Role: PRINCIPAL_INVESTIGATOR
CHRU de Nancy
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHRU de Nancy
Nancy, , France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2020PI098
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.